Business Opportunities and Investment Strategies for Global mRNA Therapeutics Market

Business Opportunities and Investment Strategies for Global mRNA Therapeutics Market 2023-2033

Business Opportunities and Investment Strategies for Global mRNA Therapeutics Market

Business Opportunities and Investment Strategies for Global mRNA Therapeutics Market 2023-2033


The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Opportunity and Strategy Analysis

This report focuses on identifying opportunities and strategies for investing in the global mRNA therapeutics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the mRNA therapeutics industry and market. This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global mRNA therapeutics industry.

Market Coverage & Overview

The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global mRNA therapeutics market is expected to reach $135.17 billion by 2033, growing by 16.1% annually over the coming years.

Segmentation Analysis

Highlighted with 89 tables and 92 figures, this 177-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, mRNA Type, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Product

• Prophylactic Vaccines

• Therapeutic Vaccines

• Therapeutic Drugs

By mRNA Type

• Self-amplifying mRNA

• Nucleoside-modified mRNA

• Unmodified mRNA

By Application

• Oncology

o Personalized Treatment

o Single Cancer Treatment

• Respiratory Diseases

• Infectious Diseases

• Autoimmune Diseases

• Rare Genetic Diseases

• Other Applications

By End User

• Hospitals and Clinics

• Research Organizations

• Other End Users

By Region

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Colombia, Argentina, Rest of South America)

• MEA (UAE, Saudi Arabia, Israel, and Rest of MEA)

The breakdown of all regional markets by country and the breakdown of each national market by Product, Application, and End User over the forecast years are also included.

Key Companies

The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:

• Arcturus Therapeutics

• Argos Therapeutics Inc.

• AstraZeneca Plc

• BioNTech SE

• CRISPR Therapeutics AG

• CureVac AG

• eTheRNA

• Ethris GMBH

• GlaxoSmithKline PLC

• Moderna Therapeutics Inc.

• Pfizer Inc.

• Sangamo Therapeutics Inc.

• Translate Bio Inc.

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 23

2.1.2 Impact of COVID-19 on the Market 27

2.1.3 Impact of Russia-Ukraine Conflict 29

2.1.4 Impact of Israel-Palestine War 31

2.2 Major Growth Drivers 32

2.3 Market Restraints and Challenges 37

2.4 Emerging Opportunities and Market Trends 40

2.5 Porter’s Fiver Forces Analysis 43

3 Segmentation of Global Market by Product 47

3.1 Market Overview by Product 47

3.2 Prophylactic Vaccines 50

3.3 Therapeutic Vaccines 51

3.4 Therapeutic Drugs 52

4 Segmentation of Global Market by mRNA Type 53

4.1 Market Overview by mRNA Type 53

4.2 Self-amplifying mRNA 56

4.3 Nucleoside-modified mRNA 57

4.4 Unmodified mRNA 58

5 Segmentation of Global Market by Application 59

5.1 Market Overview by Application 59

5.2 Oncology 62

5.2.1 Personalized Treatment 63

5.2.2 Single Cancer Treatment 64

5.3 Respiratory Diseases 65

5.4 Infectious Diseases 66

5.5 Autoimmune Diseases 67

5.6 Rare Genetic Diseases 68

5.7 Other Applications 69

6 Segmentation of Global Market by End User 70

6.1 Market Overview by End User 70

6.2 Hospitals and Clinics 73

6.3 Research Organizations 74

6.4 Other End Users 75

7 Segmentation of Global Market by Region 76

7.1 Geographic Market Overview 2023-2033 76

7.2 North America Market 2023-2033 by Country 81

7.2.1 Overview of North America Market 81

7.2.2 U.S. 85

7.2.3 Canada 88

7.2.4 Mexico 90

7.3 European Market 2023-2033 by Country 92

7.3.1 Overview of European Market 92

7.3.2 Germany 96

7.3.3 U.K. 98

7.3.4 France 100

7.3.5 Spain 102

7.3.6 Italy 104

7.3.7 Russia 106

7.3.8 Rest of European Market 108

7.4 Asia-Pacific Market 2023-2033 by Country 110

7.4.1 Overview of Asia-Pacific Market 110

7.4.2 Japan 114

7.4.3 China 117

7.4.4 Australia 119

7.4.5 India 121

7.4.6 South Korea 123

7.4.7 Rest of APAC Region 125

7.5 South America Market 2023-2033 by Country 127

7.5.1 Argentina 131

7.5.2 Brazil 133

7.5.3 Colombia 135

7.5.4 Rest of South America Market 137

7.6 MEA Market 2023-2033 by Country 138

7.6.1 UAE 142

7.6.2 Saudi Arabia 144

7.6.3 Israel 146

7.6.4 Other National Markets 148

8 Competitive Landscape 149

8.1 Overview of Key Vendors 149

8.2 New Product Launch, Partnership, Investment, and M&A 153

8.3 Company Profiles 154

Arcturus Therapeutics 154

Argos Therapeutics Inc. 156

AstraZeneca Plc 157

BioNTech SE 158

CRISPR Therapeutics AG 159

CureVac AG 160

eTheRNA 161

Ethris GMBH 162

GlaxoSmithKline PLC 163

Moderna Therapeutics Inc. 164

Pfizer Inc. 165

Sangamo Therapeutics Inc. 166

Translate Bio Inc. 167

9 Investing in mRNA Therapeutics Industry: Risk Assessment and Management 168

9.1 Risk Evaluation of Global Market 168

9.2 Critical Success Factors (CSFs) 174

RELATED REPORTS 177

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
mRNA Therapeutics Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Is the mRNA Therapeutics Market shifting its focus from growth to value?
Recognize the areas along the mRNA Therapeutics Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What years are taken into account in the mRNA Therapeutics Market study?
The mRNA Therapeutics Market study evaluates the year spans as follows: Historical year: 2019 to 2024; Base year: 2024; Forecast period**: 2025 to 2030 [** unless otherwise stated]
Is further segmentation possible given the scope of the mRNA Therapeutics Market study?
Yes, the add-on segmentation is available in the premium customised version of the mRNA Therapeutics Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
What makes the latest mRNA Therapeutics Market study unique?
The latest version of the mRNA Therapeutics Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.